TNI BioTech, Inc. Signs Exclusive Distributor Agreement for Federal Republic of Nigeria to Treat Fatal Diseases w/ Affordable Drug - LDN

FINALLY!!!!  ANOTHER one... Oh man ...I can't take it! Another Happy articles !!!.  Thank you God!  lol

This drug, LDN, will work wonders for the diseases killing the population of Nigeria.  It's been years and years of waiting on a drug that wouldn't work well, but be within a decent price range.  Finally these people will get the help they need that will hopefully extend their lives and improve the quality of them as well.  

ARTICLE HIGHLIGHTS

• According to Frank Aribeana, the managing member of G-Ex Technologies/St Maris Pharma, "We are delighted to enter into this agreement as we believe the introduction of IRT-103 LDN and IRT-104 LDN cream in this market will allow us to provide much needed treatment at an affordable price to the citizens of the Federal Republic of Nigeria."     E P I C   N E W S
• TNI BioTech, Inc., is a biotech company combating fatal diseases through the activation and mobilization of the body's immune system using our patented immunotherapy. Our products and immunotherapy technologies are designed to harness the power of the immune system to improve the treatment of cancer, infections such as HIV/AIDS, chronic inflammatory diseases, and autoimmune diseases.
• most advanced clinical programs involve immunotherapy that works by isolating a patient's lymphocytes and then incubating them together with Methionine Enkephalin (MENK) in an enriching external incubation system. After incubation the patient's lymphocytes are re-infused back into the patient where they combat and destroy tumor cells.
  
  Read more here: http://www.sacbee.com/2012/11/15/4988198/tni-biotech-inc-signs-exclusive.html#storylink=cpy
  
  Read more here: http://www.sacbee.com/2012/11/15/4988198/tni-biotech-inc-signs-exclusive.html#storylink=cpy

TNI BioTech, Inc. Signs Exclusive Distributor Agreement for Federal Republic of Nigeria with G-Ex Technologies/St. Maris Pharma & GB Pharma Holdings LLC

By TNI BioTech, Inc.

Published: Thursday, Nov. 15, 2012 - 6:31 am

NEW YORK, Nov. 15, 2012 -- /PRNewswire/ -- TNI BioTech, Inc. (Pinksheets: TNIB) announced today the signing of an exclusive distributor agreement with G-Ex Technologies/St. Maris Pharma & GB Pharma Holdings LLC for the Federal Republic of Nigeria.  Under the terms of the agreement, G-Ex Technologies/St. Maris Pharma & GB Pharma Holdings LLC will have exclusive marketing and distribution rights to IRT-103 LDN and IRT-104 LDN cream in Nigeria. TNIB will be responsible for the manufacture and supply of IRT-103 LDN and IRT-104 LDN cream. The therapies, developed as a treatment for cancer, HIV/AIDS and other autoimmune diseases, will be manufactured in TNI BioTech, Inc.'s facility in Managua, Nicaragua under the supervision and quality control of Dr. Henry "Skip" Lenz.  G-Ex Technologies/St. Maris Pharma, as part of the agreement, will provide TNIB with a revolving letter of credit for the minimum purchase of 750,000 doses monthly of IRT-103 LDN or IRT-104 LDN cream beginning March 1, 2013 priced at $1.00 dollar per dose. 

The agreements calls for G-Ex Technologies/St. Maris Pharma & GB Pharma Holdings LLC to purchase a minimum of 15,000,000 doses monthly within 24 months to maintain their exclusive agreement. Once G-Ex Technologies/St. Maris Pharma & GB Pharma Holdings LLC reach sales of 1,000,000 million doses per day TNIB has agreed to joint venture a factory in the Federal Republic of Nigeria to meet local demands.

Noreen Griffin, CEO of TNI BioTech, Inc. said "this contract shows TNI BioTech's commitment to generate revenue during our first year of operations."

According to Frank Aribeana, the managing member of G-Ex Technologies/St Maris Pharma, "We are delighted to enter into this agreement as we believe the introduction of IRT-103 LDN and IRT-104 LDN cream in this market will allow us to provide much needed treatment at an affordable price to the citizens of the Federal Republic of Nigeria."

About G-Ex Technologies/St. Maris Pharma G.Ex Technologies/St. Maris Pharma is a consortium of management consultant, general pharmaceutical, clinical pharmacy and marketing executives, each with over twenty-five years of industry experience and well versed in the changing dynamics of the prescription and OTC drug international marketplace. Actively supported by medical practice professionals in business and academia who have been involved in the management of related drug therapies for many years, the consortium is poised to champion the successful introduction of IRT-103 LDN and IRT-104 LDN in the territory.  

About TNI BioTech, Inc. TNI BioTech, Inc., is a biotech company combating fatal diseases through the activation and mobilization of the body's immune system using our patented immunotherapy. Our products and immunotherapy technologies are designed to harness the power of the immune system to improve the treatment of cancer, infections such as HIV/AIDS, chronic inflammatory diseases, and autoimmune diseases.

Our proprietary technology, therapies and patents, will be used to treat a wide range of cancers. Our most advanced clinical programs involve immunotherapy that works by isolating a patient's lymphocytes and then incubating them together with Methionine Enkephalin (MENK) in an enriching external incubation system. After incubation the patient's lymphocytes are re-infused back into the patient where they combat and destroy tumor cells.

Even though Management considers any condition that results in altered-immune response a target for investigation, the Company will most likely pursue additional investigations for MENK as a valuable candidate in the treatment of the following:

• Autoimmune states such as rheumatoid arthritis and multiple sclerosis;
• As an adjunct to antibiotics in the treatment of infectious diseases;
• In cancer patients undergoing chemotherapy, radiation treatments or surgery;
• Patients with AIDS, in combination with retroviral drug therapy; and
• In wound healing or herpes viral infections.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release includes various "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which represent the Company's expectations or beliefs concerning future events. Statements containing expressions such as "believes," "anticipates," "intends," or "expects," used in the Company's press releases and in Disclosure Statements and Reports filed with the Over The Counter Markets through the OTC Disclosure and News Service are intended to identify forward-looking statements. All forward-looking statements involve risks and uncertainties. Although the Company believes its expectations are based upon reasonable assumptions within the bounds of its knowledge of its business and operations, there can be no assurances that actual results will not differ materially from expected results. The Company cautions that these and similar statements included in this report are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date thereof. The Company undertakes no obligation to publicly release any revisions to such forward-looking statements to reflect events or circumstances after the date hereof. Contact: Global Investment Media

Phone:  310-353-6277

SOURCE TNI BioTech, Inc.

Read more here: http://www.sacbee.com/2012/11/15/4988198/tni-biotech-inc-signs-exclusive.html#storylink=cpy

TNI BioTech, Inc. Signs Exclusive Distributor Agreement for Federal Republic of Nigeria with G-Ex Technologies/St. Maris Pharma & GB Pharma Holdings LLC - PR Newswire - The Sacramento Bee:

'via Blog this'

*ViDEO*Semi-Vegetarian Diet & Effects On Reaching Remission in Crohn's Disease -

"Meat (including fish),  cheese, and animal protein intake in general have been associated with an increased risk of inflammatory bowel disease (IBD). In the meantime, plant-based diets may not only help prevent such conditions, but treat them as well, resulting in the longest recorded remission rates for Crohn’s disease."

Dietary Treatment of Crohn's Disease | NutritionFacts.org:

'via Blog this'

Nick Cannon - Just 1 More Case Of The so called "non curable" Auto-Immune Disease

I'm so damn sick of hearing the word "AUTOIMMUNE DISEASE".  If the immune system doesn't work as it should and is "diseased" because it's attacking  areas of the body that are perfectly healthy, how in the world did this begin, when did it start, why do the majority of elderly people and even people aged 50 and up not have he threat of these disease?  & if you know about Autoimmune conditions, there are at least over 20 conditions that fall into the category... if not more.  
Our generation, up coming generation, and our poor children's generation are faced with these, or will be faced with these horrible health challenges.  They are almost doomed once they are conceived because they are already being fed the trash that comes from the food of the mother.  
I don't want to raise my family here, in the US with the health care only becoming more bleak as the years go on.  Our health 20 years ago compared to today is TERRIBLE.... &only getting worse.  Our nation  has all some of the greatest medical advances, technology, drugs, so WTF is the problem???  It's sickening that so many people are suffering with these diseases that the doctors say "can only be managed".  
That's a lie and I'm beginning to have hatred toward the entire medical system.


Before I forget to mention, someone will think to themselves. 'Well, death rates are much older than they used to be.  People are living to be well into their 80's.  That's true... but what kind of qualityof life are they living.  Are they existing, in chronic pain, spending all their money on health care to "manage" their health condition.  
My guess.... is that they aren't living the best life they could possibily be living, unless they are just solid and healthy people, if they refuse to just take the pill and live (putting up with the pain). Other's don't suffer from the condition in a way that it interferes in their daily life, so those people only complain, call the doctor and get more meds to give temp. relieve, but most likely, so many meds these days, precipitate more health problems.


This is my vent.  I'm fed up and annoyed!!  I hear AUTOIMMUNE way to much, but why isn't anything being done to treat the person in a way that wont harm them further, if not send them to their grave!!!!! 

Nick Cannon: I have an auto-immune disease - 21 News Now, More Local News for Youngstown, Ohio -

Julia Schopick -Speaks about Low Dose Naltrexone *VIDEO*

Author of "Honest Medicine", Julia Schopick speaks briefly about LDN/Low Dose Naltrexone for severe diseases that often do not respond well to mainstream treatments. Short video that gives brief information about how LDN works and she speaks of the founder of LDN, Doctor Bihari.

In Julia's book, "Honest Medicine", she introduces four lifesaving treatments that have been effectively treating—and in some cases curing—people for 25-90 years. However, for reasons of profitability (or lack thereof), these treatments have not been universally accepted. The treatments are:

Low Dose Naltrexone for autoimmune diseases (e.g., multiple sclerosis, lupus, rheumatoid arthritis, Crohn's disease) HIV/AIDS and some cancers

The Ketogenic Diet for pediatric epilepsy

Intravenous alpha lipoic acid, for terminal liver disease and some cancers

Silverlon for non-healing wounds.

Julia Schopick's Site - http://www.honestmedicine.com